General
Preferred name
AFIMOXIFENE
Synonyms
4-hydroxytamoxifen ()
4-Hydroxytamoxifen (Afimoxifene) ()
(E/Z)-4-hydroxy Tamoxifen ()
(E/Z)-4-hydroxy Tamoxifen-d5 ()
P&D ID
PD017818
CAS
68392-35-8
2470232-57-4
Tags
available
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Afimoxifene (4-hydroxytamoxifen) is a selective estrogen receptor modulator which is the active metabolite of tamoxifen. Afimoxifene is a transdermal gel formulation and is being developed by Ascend Therapeutics, Inc. under the trademark TamoGel. Afimoxifene has completed a phase II clinical trial for the treatment of cyclical mastalgia. (BOC Sciences Bioactive Compounds)
Cell lines
13
Organisms
0
Compound Sets
4
BOC Sciences Bioactive Compounds
afimoxifene-cas-68392-35-8-351000
Cayman Chemical Bioactives
17308
34232
Selleckchem Bioactive Compound Library
4-hydroxytamoxifen-4-ht-afimoxifene
TargetMol Bioactive Compound Library
T6743
External IDs
19
Properties
(calculated by RDKit )
Molecular Weight
387.22
Hydrogen Bond Acceptors
3
Hydrogen Bond Donors
1
Rotatable Bonds
8
Ring Count
3
Aromatic Ring Count
3
cLogP
5.7
TPSA
32.7
Fraction CSP3
0.23
Chiral centers
0.0
Largest ring
6.0
QED
0.5
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Pathway
Endocrinology/Hormones
Target
ER
CRISPR/Cas9,Estrogen/progestogen Receptor
MOA
Estrogen/Progestogen Receptor modulator
Solubility
Soluble in Dichloromethane (Slightly), Methanol (Slightly)
Source data